Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
95.21
+0.10 (0.11%)
At close: May 9, 2025, 4:00 PM
96.17
+0.96 (1.01%)
After-hours: May 9, 2025, 7:46 PM EDT
Zimmer Biomet Holdings Stock Forecast
Stock Price Forecast
The 21 analysts with 12-month price forecasts for Zimmer Biomet Holdings stock have an average target of 115.95, with a low estimate of 95 and a high estimate of 150. The average target predicts an increase of 21.78% from the current stock price of 95.21.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Zimmer Biomet Holdings stock from 23 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
Buy | 5 | 5 | 6 | 6 | 6 | 7 |
Hold | 12 | 12 | 12 | 12 | 12 | 11 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Total | 21 | 22 | 23 | 23 | 23 | 23 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JMP Securities | JMP Securities | Buy Maintains $140 → $125 | Buy | Maintains | $140 → $125 | +31.29% | May 7, 2025 |
Goldman Sachs | Goldman Sachs | Hold Maintains $120 → $104 | Hold | Maintains | $120 → $104 | +9.23% | May 6, 2025 |
Raymond James | Raymond James | Buy Maintains $119 → $104 | Buy | Maintains | $119 → $104 | +9.23% | May 6, 2025 |
Stifel | Stifel | Strong Buy Maintains $138 → $115 | Strong Buy | Maintains | $138 → $115 | +20.79% | May 6, 2025 |
RBC Capital | RBC Capital | Buy Maintains $125 → $112 | Buy | Maintains | $125 → $112 | +17.63% | May 6, 2025 |
Financial Forecast
Revenue This Year
7.97B
from 7.68B
Increased by 3.82%
Revenue Next Year
8.35B
from 7.97B
Increased by 4.74%
EPS This Year
8.29
from 4.43
Increased by 87.23%
EPS Next Year
8.94
from 8.29
Increased by 7.81%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 8.5B | 9.0B | 9.3B | ||
Avg | 8.0B | 8.4B | 8.7B | ||
Low | 7.7B | 8.0B | 8.3B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 10.1% | 12.7% | 11.0% | ||
Avg | 3.8% | 4.7% | 3.9% | ||
Low | -0.2% | -0.2% | -1.0% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 8.74 | 9.68 | 10.90 | ||
Avg | 8.29 | 8.94 | 9.72 | ||
Low | 7.78 | 8.31 | 9.01 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 97.2% | 16.7% | 21.9% | ||
Avg | 87.2% | 7.8% | 8.7% | ||
Low | 75.6% | 0.2% | 0.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.